Graf Acquisition Corp IV (GFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GFOR | LIXT | AARD | ||
| Company | Graf Acquisition Corp IV | Lixte Biotech Hlds | Aardvark Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 7.14 | 6.83 | 3.91 | ||
| High | 9.45 | 7.48 | 3.98 | ||
| Low | 7.07 | 6.69 | 3.66 | ||
| Latest | 8.30 | 7.00 | 3.68 | ||
| Change | +0.40 | unch | -0.26 | ||
| % Change | +5.06% | unch | -6.60% | ||
| Volume | 119,000 | 149,700 | 139,800 | ||
| 20-Day Average Volume | 289,020 | 165,345 | 191,465 | ||
| Previous Close | 7.90 | 7.00 | 3.94 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.67 | 5.86 | 4.66 | ||
| 20-Day Raw Stochastic | 41.80% | 85.42% | 0.64% | ||
| 20-Day Relative Strength | 41.03 | 68.61 | 37.28 | ||
| Weighted Alpha | -22.80 | +29.67 | -68.83 | ||
| Today's Opinion | 88% Sell | 88% Buy | 100% Sell | ||
| Previous Opinion | 72% Sell | 88% Buy | 88% Sell | ||
| Last Month's Opinion | 64% Buy | 24% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.18% since 09/22/23 | +12.00% since 05/29/26 | -10.46% since 05/29/26 | ||
| Low | 5.01 on 09/28/23 | 5.80 on 06/01/26 | 3.66 on 06/05/26 | ||
| High | 10.41 on 09/25/23 | 7.50 on 06/02/26 | 4.12 on 06/01/26 | ||
| 1-Month | |||||
| %Chg | -26.16% since 08/29/23 | +56.08% since 05/05/26 | -32.72% since 05/05/26 | ||
| Low | 5.01 on 09/28/23 | 3.96 on 05/06/26 | 3.66 on 06/05/26 | ||
| High | 12.88 on 09/19/23 | 7.50 on 06/02/26 | 6.79 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | -19.57% since 06/28/23 | +162.17% since 03/05/26 | -35.89% since 03/05/26 | ||
| Low | 5.01 on 09/28/23 | 2.36 on 03/09/26 | 3.35 on 03/27/26 | ||
| High | 12.88 on 09/19/23 | 7.50 on 06/02/26 | 6.79 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | -18.47% since 03/29/23 | +72.84% since 12/05/25 | -72.86% since 12/05/25 | ||
| Low | 5.01 on 09/28/23 | 2.36 on 03/09/26 | 3.35 on 03/27/26 | ||
| High | 12.88 on 09/19/23 | 7.50 on 06/02/26 | 16.60 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 86,104 | 86,681 | 85,955 | ||
| Shares Outstanding, K | 10,374 | 12,383 | 21,816 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 4,550,000 | -6,010,000 | -57,590,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -1,830,000 | -1,920,000 | -21,590,000 | ||
| 60-Month Beta | 0.03 | 1.27 | 4.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/14/23 | -0.18 on 05/14/26 | -0.99 on 05/07/26 | ||
| Earnings Date | 01/01/70 | 08/06/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||